Your browser doesn't support javascript.
loading
Real-world treatment patterns and clinical outcomes of HCV treatment-naive patients in China: an interim analysis from the CCgenos study.
Rao, Hui-Ying; Li, Hong; Chen, Hong; Shang, Jia; Xie, Qing; Gao, Zhi-Liang; Li, Jun; Sun, Yongtao; Jiang, Jianning; Wang, Lei; Zhao, Longfeng; Zhang, Lunli; Yang, Weibo; Niu, Junqi; Gong, Zuojiong; Gong, Guozhong; Yang, Ruifeng; Lee, Mei-Hsuan; Wei, Lai.
Afiliação
  • Rao HY; Peking University Hepatology Institute, Beijing Key Laboratory for Hepatitis C and Immunotherapy for Liver Disease, Peking University People's Hospital, Beijing.
  • Li H; Bristol-Myers Squibb, Wallingford.
  • Chen H; The First Hospital of Lanzhou University, Lanzhou.
  • Shang J; Henan Provincial People's Hospital, Zhengzhou.
  • Xie Q; Shanghai Ruijin Hospital, Jiaotong University School of Medicine, Shanghai.
  • Gao ZL; The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou.
  • Li J; The First Affiliated Hospital of Nanjing Medical University, Nanjing.
  • Sun Y; Tangdu Hospital, Xi'an.
  • Jiang J; The First Affiliated Hospital of Guangxi Medical University, Nanning.
  • Wang L; The Second Hospital of Shandong University, Jinan.
  • Zhao L; The First Affiliated Hospital of Shanxi Medical University, Taiyuan.
  • Zhang L; The First Affiliated Hospital of Nanchang University, Nanchang.
  • Yang W; The First Affiliated Hospital of Kunming Medical University, Kunming.
  • Niu J; The First Hospital of Jilin University, Changchun.
  • Gong Z; Renmin Hospital of Wuhan University, Wuhan.
  • Gong G; The Second Xiangya Hospital of Central South University, Changsha.
  • Yang R; Peking University Hepatology Institute, Beijing Key Laboratory for Hepatitis C and Immunotherapy for Liver Disease, Peking University People's Hospital, Beijing.
  • Lee MH; Institute of Clinical Medicine, National Yang-Ming University, Taipei.
  • Wei L; Peking University Hepatology Institute, Beijing Key Laboratory for Hepatitis C and Immunotherapy for Liver Disease, Peking University People's Hospital, Beijing.
J Gastroenterol Hepatol ; 32(1): 244-252, 2017 Jan.
Article em En | MEDLINE | ID: mdl-27289083

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferons / Hepatite C Crônica Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Gastroenterol Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferons / Hepatite C Crônica Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Gastroenterol Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2017 Tipo de documento: Article